REVB earnings: next report 2026-08-07, real EPS beat/miss history, analyst consensus Buy, P/E -0.09. Updated 2026-07-23.
Revelation Biosciences (REVB) Research Hub
Revelation Biosciences (REVB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.9924 USD (-1.74%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.09, market cap 0.00B. This hub links to the full technical, earnings and options research available for REVB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9924 USD (-1.74%) |
| 52-week range | 0.91 USD – 1.23 USD |
| Trend regime | Range |
| 14-day RSI | 34.1 (Bearish) |
| Trailing P/E | -0.09 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-07 |
Available research for REVB
Covered Call on REVB: how it works, illustrative setup around the real 0.9924 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on REVB: how it works, illustrative setup around the real 0.9924 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on REVB: how it works, illustrative setup around the real 0.9924 USD price, max profit/loss, breakeven and when to use it. Educational.
REVB technical analysis: range, last 0.9924 USD, RSI 34.1, 52w range 0.91 USD–1.23 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is REVB in?
Revelation Biosciences (REVB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is REVB in an uptrend or downtrend?
As of 2026-09-11, REVB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is REVB's trailing P/E ratio?
REVB's trailing P/E is -0.09, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does REVB next report earnings?
REVB is next scheduled to report earnings on 2026-08-07, with a consensus EPS estimate of -0.83 USD.